How much will investors pay for Rowsley?

How much will investors pay for Rowsley?

Michelle Teo
28/07/17, 10:07 am

SINGAPORE (July 31): Billionaire former stockbroker Peter Lim is on his way to transforming Rowsley into a healthcare company — by injecting into the public-listed company assets that are already familiar to the market.

Before investors jump on the stock, however, they should look closely at the market value it has already garnered.

See: Rowsley shares up some 58% on deal to buy healthcare assets for $1.9 bil

On July 18, Rowsley said it planned to acquire 100% of a privately held company called Sasteria, which Lim fully controls. Sasteria wholly owns Thomson Medical Pte Ltd, which in turn owns Thomson Medical Centre, a premium 190-bed healthcare facility that specialises in maternity care and fertility treatments.

Rowsley will pay $1.9 billion for Sasteria, by issuing 25.3 billion new shares at 7.5 cents each. This is 2.7% more than Rowsley’s last traded price of 7.3 cents prior to the announcement, but 13% less than Rowsley’s net asset value of 8.63 cents a share.

As part of the whole exercise, all existing shareholders will also receive two bonus warrants for every share they currently hold. The bonus warrants will have an exercise price of nine cents. Each bonus warrant will come with a “piggyback” warrant, with an exercise price of 12 cents.

Lim currently owns more than 45.3% of Rowsley. With the 25.3 billion shares to be issued for the purchase of Sasteria, Lim’s stake in the enlarged Rowsley will be more than 90%.

According to Rowsley, Lim is seeking a waiver of the obligation to make a mandatory offer for the company under the Takeover Code.

Rowsley did not say whether Lim planned to sell any of his shares to widen the free float.

Ng Ser Miang, chairman of Rowsley, says in a statement that the acquisition of Sasteria will “significantly increase” the company’s market capitalisation and market profile, and generate investor interest. Indeed, after the acquisition was announced, shares in Rowsley rocketed.

On July 20, they traded at as much as 19.8 cents, up 171% from before the acquisition of Sasteria was announced. Since then, the stock has retraced significantly, to close at 11 cents on Friday.

Is Rowsley getting a good deal, and are its shares getting too high? After all, buying the stock now for the healthcare acquisitions is akin to buying shares in a newly listed healthcare company after its shares have popped on the first few days of trading.

Find out more as we take a look into the group’s plan to buy $1.9 billion in healthcare assets, and what it means for investors, in this week’s issue of The Edge Singapore (Issue 790, week of Jul 31), available at newsstands, bookstores, gas stations and 7-11 outlets.  

US sanctions on Huawei could backfire

SINGAPORE (May 27): It was only to have been expected. After nearly a year of pressure that failed to stop Huawei Technologies Co’s expansion -- especially in the rollout of the next generation 5G wireless network globally -- in its tracks, US President Donald Trump signed an executive order effectively barring American firms from doing business with the Chinese telecommunications equipment company. The inclusion of Huawei on the US Department of Commerce’s Bureau of Industry and Security’s (BIS) Entity List means that companies would need to apply for a waiver to supply goods with 25....

Annica chairman Ong quits just as $33 mil goes missing at his law firm JLC

SINGAPORE (May 27): Jeffrey Ong, managing partner of law firm JLC Advisors, may have given instructions to pay out a sum of $33.2 million held in escrow by his firm for a client, Allied Technologies. According to Allied’s statement filed with Singapore Exchange on May 23, the payment may have been “unauthorised”, citing a letter it received from JLC on May 22. Allied’s statement did not specify who the payment was made to. Ong also abruptly resigned as non-executive chairman of Annica Holdings on May 20. In a May 22 filing with SGX, Annica CEO Sandra Liz Hon Ai Ling said Ong resigne....

SGX RegCo sees targeted approach in enforcement, more powerful market discipline

SINGAPORE (May 27): Tan Boon Gin, CEO of stock exchange regulator Singapore Exchange Regulation, says the market can expect a stronger regulatory presence. “You will see a series of enforcement cases coming up quite soon,” he tells The Edge Singapore. Tan’s assertion comes amid significant changes in the market as sentiment remains lacklustre and investors’ expectations change. The local stock market has gone through significant upheaval, not least because of the penny stock crash in 2013 that wiped out some $8 billion in value from the market. The event dented investor sentiment, a....